Reversible nefazodone-induced liver failure.
Eloubeidi
M A
MA
Liver Center, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
Gaede
J T
JT
Swaim
M W
MW
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D001706:Biopsy; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis* / Q000473:pathology; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008099:Liver / Q000473:pathology; D008104:Liver Cirrhosis, Alcoholic / Q000175:diagnosis / Q000473:pathology; D017093:Liver Failure / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D008875:Middle Aged; D010879:Piperazines; D014230:Triazoles / Q000009:adverse effects* / Q000627:therapeutic use
D018687:Antidepressive Agents, Second-Generation; D010879:Piperazines; D014230:Triazoles; C051752:nefazodone